Skip Navigation

Cardiovascular Research 2005 68(2):318-326; doi:10.1016/j.cardiores.2005.06.011
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wu, R.
Right arrow Articles by Wang, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, R.
Right arrow Articles by Wang, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1

Rongqian Wu, Weifeng Dong, Mian Zhou, Xiaoxuan Cui, H. Hank Simms1 and Ping Wang*

Center for Immunology and Inflammation, Institute for Medical Research, North Shore-Long Island Jewish (LIJ) Health System, USA
Division of Surgical Research, North Shore University Hospital and LIJ Medical Center, Manhasset, NY 11030, USA

* Corresponding author. Division of Surgical Research, North Shore University Hospital and LIJ Medical Center, Manhasset, NY 11030, USA. Tel.: +1 516 562-9445; fax: +1 516 562-2396. Email address: pwang{at}nshs.edu

Objectives: Severe sepsis is associated with increased total peripheral resistance (TPR) and decreased organ blood flow, in which endothelin-1 (ET-1) plays an important role. Plasma levels of ghrelin, a newly-identified endogenous ligand for growth hormone secretagogue receptor and a potent vasodilatory peptide, are significantly reduced in sepsis. Ghrelin downregulation heralds the hypodynamic response in severe sepsis. Therefore, we hypothesized that the administration of exogenous ghrelin improves organ blood flow by downregulation of ET-1 under such conditions.

Methods: Male adult Sprague–Dawley rats were subjected to sepsis by cecal ligation and puncture (CLP). At 5 h post-CLP, a bolus intravenous injection of 2 nmol ghrelin was followed by a continuous infusion of 12 nmol ghrelin via a primed mini-pump over 15 h. At 20 h post-CLP (i.e., severe sepsis), cardiac output (CO), stroke volume (SV), TPR, and organ blood flow were measured using 141Ce-microspheres. Plasma ET-1 levels and preproET-1 gene expression in the liver, small intestine, and kidneys were measured by ELISA and RT-PCR, respectively. The direct effect of ghrelin on ET-1 production was studied using cultured human umbilical vein endothelial cells (HUVECs) treated with tumor necrosis factor-{alpha} (TNF-{alpha}).

Results: Ghrelin administration reduced TPR, increased CO, SV, and organ blood flow, downregulated preproET-1 gene expression, and decreased plasma levels of ET-1 in sepsis. Ghrelin inhibited TNF-{alpha}-induced ET-1 release from HUVECs in a dose-dependent manner. Moreover, ghrelin inhibited TNF-{alpha}-induced activation of nuclear factor-{kappa}B (NF-{kappa}B) in HUVECs.

Conclusions: The improvement of tissue perfusion by ghrelin in severe sepsis appears to be mediated by downregulation of ET-1 involving a NF-{kappa}B-dependent pathway.

KEYWORDS Peptide hormones; Sepsis; Blood flow; Endothelin-1; Nuclear factor-{kappa}B


1 Current address: Department of Surgery, Albert Einstein Medical Center, Philadelphia, PA 19141, USA.

Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
M. Tesauro, F. Schinzari, V. Rovella, N. Di Daniele, D. Lauro, N. Mores, A. Veneziani, and C. Cardillo
Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome
Hypertension, November 1, 2009; 54(5): 995 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Wang, S. Bansal, S. Falk, D. Ljubanovic, and R. Schrier
Ghrelin protects mice against endotoxemia-induced acute kidney injury
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F1032 - F1037.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Chorny, P. Anderson, E. Gonzalez-Rey, and M. Delgado
Ghrelin Protects against Experimental Sepsis by Inhibiting High-Mobility Group Box 1 Release and by Killing Bacteria
J. Immunol., June 15, 2008; 180(12): 8369 - 8377.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L. D Madison, J. M Scarlett, P. Levasseur, X. Zhu, K. Newcomb, A. Batra, D. Bowe, and D. L Marks
Prostacyclin signaling regulates circulating ghrelin during acute inflammation
J. Endocrinol., February 1, 2008; 196(2): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. O. Schwenke, T. Tokudome, M. Shirai, H. Hosoda, T. Horio, I. Kishimoto, and K. Kangawa
Exogenous Ghrelin Attenuates the Progression of Chronic Hypoxia-Induced Pulmonary Hypertension in Conscious Rats
Endocrinology, January 1, 2008; 149(1): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Wu, M. Zhou, P. Das, W. Dong, Y. Ji, D. Yang, M. Miksa, F. Zhang, T. S. Ravikumar, and P. Wang
Ghrelin inhibits sympathetic nervous activity in sepsis
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1697 - E1702.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Wu, W. Dong, M. Zhou, F. Zhang, C. P. Marini, T. S. Ravikumar, and P. Wang
Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in Rats
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 805 - 813.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.